Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03724890
Title Study of Avelumab-M3814 Combinations
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center and Research Institute, Inc Tampa Florida 33612 United States Details
The University of Chicago Medical Center Chicago Illinois 60637 United States Details
Mount Sinai - PRIME (10707) Lake Success New York 11041 United States Details
UC Health Clinical Trials Office (10702) Cincinnati Ohio 45267-0502 United States Details
University of Oklahoma Health Sciences Center - Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
University of Pittsburgh Medical Center Health System Pittsburgh Pennsylvania 15213 United States Details
Greenville Hospital System University Medical Center (ITOR) Greenville South Carolina 29605 United States Details
Vanderbilt-Ingram Cancer Center (8867) Nashville Tennessee 37212 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field